W
Walter M. Stadler
Researcher at University of Chicago
Publications - 513
Citations - 37554
Walter M. Stadler is an academic researcher from University of Chicago. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 88, co-authored 494 publications receiving 34323 citations. Previous affiliations of Walter M. Stadler include Cleveland Clinic & Northwestern University.
Papers
More filters
Journal ArticleDOI
No interest, no conflict
TL;DR: In this issue of Cancer, Desai et al have described the financial conflict of interest (FCOI) disclosures among panelists on the National Comprehensive Cancer Network (NCCN) clinical practice guidelines committees and made specific suggestions regarding how NCCN guideline committees could come into closer alignment with IOM recommendations.
Book ChapterDOI
Renal Cell Carcinoma
Olwen Hahn,Walter M. Stadler +1 more
TL;DR: The recent Food and Drug Administration’s approval of two multi-tyrosine kinase inhibitors and encouraging results from a phase III trial of a mammalian target of rapamycin (mTOR) inhibitor represent significant advances in the treatment of metastatic renal cancer.
Androgen R eceptor M utations i n A ndrogen-Indepen dent Prostate C ancer: C ancer a nd L eukemia G roup B S tudy 9 663
Mary-Ellen Taplin,Barur R. Rajeshkumar,Susan Halabi,Cary P. Werner,Bruce A. Woda,Joel Picus,Walter M. Stadler,Daniel F. Hayes,Philip W. Kantoff,Nicholas J. Vogelzang,Eric J. Small +10 more
TL;DR: Bone marrow specimens containing prostate tumor were obtained from men undergoing antiandrogen withdrawal for AR sequence analysis and clinical correlation as mentioned in this paper, which indicated that AR mutations are present in approximately 10% of patients with prostate cancer who experience treatment failure with hormone therapy that included an anti-androgen.